sarepta therapeutics inc
(AB3A:German Stock Exchange)
Sandesh Mahatme LL.M.
Chief Financial Officer, Chief Accounting Officer and Senior Vice President, Sarepta Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 7 board members in 1 different organizations across 2 different industries.|
See Board Relationships
As of Fiscal Year 2013
Mr. Sandesh Mahatme, also known as Sandy, LL.M., has been the Chief Financial Officer and Senior Vice President of Sarepta Therapeutics, Inc. since November 5, 2012 and Chief Accounting Officer since October 4, 2013. Prior to Sarepta, Mr. Mahatme served in various roles including Senior Vice President of Corporate Development, Corporate Treasurer and Senior Vice President of Tax at Celgene Corporation since 2006. While at Celgene, he was instrumental in building Celgene's ...
215 First StreetPhone: 617-274-4000
Cambridge, Massachusetts 02142
Board Members Memberships*
Director and Chairman of Audit Committee
Cornell University School of Law
New York University School Of Law
|John C. Martin Ph.D.||Chairman and Chief Executive Officer|
Gilead Sciences Inc.
|William A. Carter M.D.||Chairman, Chief Executive Officer, President, Chief Scientific Officer, Chairman of Executive Committee, Member of Strategic Planning Committee and Member of Disclosure Controls Committee|
Hemispherx Biopharma, Inc.
|Robert L. Parkinson Jr.||Chairman, Chief Executive Officer and President|
Baxter International Inc.
|Friedhelm Blobel Ph.D.||Chief Executive Officer, President, Executive Director and Member of Business Development Committee|
SciClone Pharmaceuticals, Inc.
|Pascal Soriot||Chief Executive Officer, Executive Director and Member of Disclosure Committee|
|3.1M GBP||Compensation as of Fiscal Year 2014.|